We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company
Automated ELISA-IFA-BLOT Processor AP 22
New
Platinum Supplier
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
New
Integrated Chemistry & Immunoassay System
Dimension RxL Max
New
Semi-Automatic Coagulation Analyzer
Clot SP
Visit expo >

Download Mobile App




Image: ROTEM delta analysis helps optimize patient treatment and monitor results. Four channels and a comprehensive reagent portfolio aid in the evaluation of coagulopathies (Photo courtesy of Werfen)

Thromboelastometry Predicts Thromboembolic Events in COVID-19 Patients

In addition to severe pulmonary and renal injury, abnormality of hemostasis is recognized as a contributing factor to the severity of the COVID-19. Thromboembolic complications were diagnosed in 31% of patients with COVID-19 infection admitted to an intensive care unit, despite anticoagulation therapy. More...
05 Jul 2022
Image: New antibody detection method for coronavirus that does not require blood sample (Photo courtesy of University of Tokyo)

Antibody-Based Method Detects SARS-CoV-2 Without Blood Sample

Investigators have developed a new antibody-based method for the rapid and reliable detection of SARS-CoV-2 that does not require a blood sample. More...
04 Jul 2022
Image: A new rapid test will keep track of immunity to SARS-CoV-2 variants (Photo courtesy of University of Toronto)

Plug-and-Play Antibody Test Keeps Track of Immunity to SARS-CoV-2 Variants

An antibody test developed to measure immunity could become a valuable tool for deciding who needs a booster and when, which will help save lives and avoid future lockdowns. More...
04 Jul 2022
Image: Determining patient’s strain previously required lengthy whole genome sequencing (Photo courtesy of UTSW)

Rapid COVID-19 Test Identifies SARS-CoV-2 Variants in Hours

Scientists can now tell which SARS-CoV-2 variant has infected a COVID-19 patient in just a few hours– a critical task that can potentially influence treatment decisions but takes days or weeks at most medical centers. More...
01 Jul 2022
Image: BD MAX molecular diagnostic respiratory viral panel is CE marked to IVD directive (Photo courtesy of BD)

COVID-19, Flu and RSV Combination Test to Increase Testing Capacity and Speed Time to Diagnosis

A new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus (RSV) can help eliminate the need for multiple tests or doctor visits and aid clinicians in implementing the right treatment plan quickly. More...
01 Jul 2022
Image: PictArray SARS-CoV-2 Antibody Test has received CE Mark (Photo courtesy of Pictor)

First-Ever SARS-CoV-2 Antibody Test Indicates Whether Patients Require COVID-19 Booster

A first-of-its-kind test enables personalized COVID-19 assessments by detecting if a patient has antibodies from a previous infection of SARS-CoV-2 or from vaccination alone. More...
23 Jun 2022
Image: SARS-CoV-2 ddPCR Kit is a partition-based endpoint RT-PCR test for the qualitative detection of nucleic acids from SARS-CoV-2 (Photo courtesy of Thermo Fisher Scientific)

SARS-Cov-2 RNA Detected in FFPE Tissue by Droplet Digital PCR

SARS-CoV-2 infection can result in diverse, multiorgan pathology, the most significant being in the lungs, heart, kidney, central nervous system, liver, lymph nodes, bone marrow, vasculature, intestine, and placenta. More...
22 Jun 2022
Copyright © 2000-2022 Globetech Media. All rights reserved.